Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Distinctive TLR7 signaling, type I IFN production, and attenuated innate and adaptive immune responses to yellow fever virus in a primate reservoir host.

Mandl JN, Akondy R, Lawson B, Kozyr N, Staprans SI, Ahmed R, Feinberg MB.

J Immunol. 2011 Jun 1;186(11):6406-16. doi: 10.4049/jimmunol.1001191. Epub 2011 Apr 22.

2.

Role of nonhuman primates in the evaluation of candidate AIDS vaccines: an industry perspective.

Staprans SI, Feinberg MB, Shiver JW, Casimiro DR.

Curr Opin HIV AIDS. 2010 Sep;5(5):377-85. doi: 10.1097/COH.0b013e32833d2e19. Review.

PMID:
20978377
3.

Similar impact of CD8+ T cell responses on early virus dynamics during SIV infections of rhesus macaques and sooty mangabeys.

Kouyos RD, Gordon SN, Staprans SI, Silvestri G, Regoes RR.

PLoS Comput Biol. 2010 Aug 26;6(8). pii: e1000901. doi: 10.1371/journal.pcbi.1000901.

4.

Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys.

Bosinger SE, Li Q, Gordon SN, Klatt NR, Duan L, Xu L, Francella N, Sidahmed A, Smith AJ, Cramer EM, Zeng M, Masopust D, Carlis JV, Ran L, Vanderford TH, Paiardini M, Isett RB, Baldwin DA, Else JG, Staprans SI, Silvestri G, Haase AT, Kelvin DJ.

J Clin Invest. 2009 Dec;119(12):3556-72. doi: 10.1172/JCI40115.

5.

Selective removal of stratum corneum by microdermabrasion to increase skin permeability.

Gill HS, Andrews SN, Sakthivel SK, Fedanov A, Williams IR, Garber DA, Priddy FH, Yellin S, Feinberg MB, Staprans SI, Prausnitz MR.

Eur J Pharm Sci. 2009 Sep 10;38(2):95-103. doi: 10.1016/j.ejps.2009.06.004. Epub 2009 Jun 25.

6.

Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression.

Engram JC, Dunham RM, Makedonas G, Vanderford TH, Sumpter B, Klatt NR, Ratcliffe SJ, Garg S, Paiardini M, McQuoid M, Altman JD, Staprans SI, Betts MR, Garber DA, Feinberg MB, Silvestri G.

J Immunol. 2009 Jul 1;183(1):706-17. doi: 10.4049/jimmunol.0803746.

7.

Bone marrow-based homeostatic proliferation of mature T cells in nonhuman primates: implications for AIDS pathogenesis.

Paiardini M, Cervasi B, Engram JC, Gordon SN, Klatt NR, Muthukumar A, Else J, Mittler RS, Staprans SI, Sodora DL, Silvestri G.

Blood. 2009 Jan 15;113(3):612-21. doi: 10.1182/blood-2008-06-159442. Epub 2008 Oct 1.

8.

Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections.

Mandl JN, Barry AP, Vanderford TH, Kozyr N, Chavan R, Klucking S, Barrat FJ, Coffman RL, Staprans SI, Feinberg MB.

Nat Med. 2008 Oct;14(10):1077-87. doi: 10.1038/nm.1871. Epub 2008 Sep 14.

PMID:
18806803
9.

Availability of activated CD4+ T cells dictates the level of viremia in naturally SIV-infected sooty mangabeys.

Klatt NR, Villinger F, Bostik P, Gordon SN, Pereira L, Engram JC, Mayne A, Dunham RM, Lawson B, Ratcliffe SJ, Sodora DL, Else J, Reimann K, Staprans SI, Haase AT, Estes JD, Silvestri G, Ansari AA.

J Clin Invest. 2008 Jun;118(6):2039-49. doi: 10.1172/JCI33814.

10.

Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines.

Miller JD, van der Most RG, Akondy RS, Glidewell JT, Albott S, Masopust D, Murali-Krishna K, Mahar PL, Edupuganti S, Lalor S, Germon S, Del Rio C, Mulligan MJ, Staprans SI, Altman JD, Feinberg MB, Ahmed R.

Immunity. 2008 May;28(5):710-22. doi: 10.1016/j.immuni.2008.02.020. Epub 2008 May 8.

11.

Early resolution of acute immune activation and induction of PD-1 in SIV-infected sooty mangabeys distinguishes nonpathogenic from pathogenic infection in rhesus macaques.

Estes JD, Gordon SN, Zeng M, Chahroudi AM, Dunham RM, Staprans SI, Reilly CS, Silvestri G, Haase AT.

J Immunol. 2008 May 15;180(10):6798-807.

12.

Short-lived infected cells support virus replication in sooty mangabeys naturally infected with simian immunodeficiency virus: implications for AIDS pathogenesis.

Gordon SN, Dunham RM, Engram JC, Estes J, Wang Z, Klatt NR, Paiardini M, Pandrea IV, Apetrei C, Sodora DL, Lee HY, Haase AT, Miller MD, Kaur A, Staprans SI, Perelson AS, Feinberg MB, Silvestri G.

J Virol. 2008 Apr;82(7):3725-35. doi: 10.1128/JVI.02408-07. Epub 2008 Jan 23.

13.

Virally induced CD4+ T cell depletion is not sufficient to induce AIDS in a natural host.

Milush JM, Reeves JD, Gordon SN, Zhou D, Muthukumar A, Kosub DA, Chacko E, Giavedoni LD, Ibegbu CC, Cole KS, Miamidian JL, Paiardini M, Barry AP, Staprans SI, Silvestri G, Sodora DL.

J Immunol. 2007 Sep 1;179(5):3047-56.

14.

Severe depletion of mucosal CD4+ T cells in AIDS-free simian immunodeficiency virus-infected sooty mangabeys.

Gordon SN, Klatt NR, Bosinger SE, Brenchley JM, Milush JM, Engram JC, Dunham RM, Paiardini M, Klucking S, Danesh A, Strobert EA, Apetrei C, Pandrea IV, Kelvin D, Douek DC, Staprans SI, Sodora DL, Silvestri G.

J Immunol. 2007 Sep 1;179(5):3026-34.

15.

Depletion of CD8+ cells in sooty mangabey monkeys naturally infected with simian immunodeficiency virus reveals limited role for immune control of virus replication in a natural host species.

Barry AP, Silvestri G, Safrit JT, Sumpter B, Kozyr N, McClure HM, Staprans SI, Feinberg MB.

J Immunol. 2007 Jun 15;178(12):8002-12.

16.

Virus subtype-specific features of natural simian immunodeficiency virus SIVsmm infection in sooty mangabeys.

Apetrei C, Gautam R, Sumpter B, Carter AC, Gaufin T, Staprans SI, Else J, Barnes M, Cao R Jr, Garg S, Milush JM, Sodora DL, Pandrea I, Silvestri G.

J Virol. 2007 Aug;81(15):7913-23. Epub 2007 May 16.

17.

Adaptation of a diverse simian immunodeficiency virus population to a new host is revealed through a systematic approach to identify amino acid sites under selection.

Vanderford TH, Demma LJ, Feinberg MB, Staprans SI, Logsdon JM Jr.

Mol Biol Evol. 2007 Mar;24(3):660-9. Epub 2006 Dec 11.

PMID:
17159231
18.

Administration of fludarabine-loaded autologous red blood cells in simian immunodeficiency virus-infected sooty mangabeys depletes pSTAT-1-expressing macrophages and delays the rebound of viremia after suspension of antiretroviral therapy.

Cervasi B, Paiardini M, Serafini S, Fraternale A, Menotta M, Engram J, Lawson B, Staprans SI, Piedimonte G, Perno CF, Silvestri G, Magnani M.

J Virol. 2006 Nov;80(21):10335-45.

19.

Evolution of the uniquely adaptable lentiviral envelope in a natural reservoir host.

Demma LJ, Vanderford TH, Logsdon JM Jr, Feinberg MB, Staprans SI.

Retrovirology. 2006 Mar 20;3:19.

20.

The AIDS resistance of naturally SIV-infected sooty mangabeys is independent of cellular immunity to the virus.

Dunham R, Pagliardini P, Gordon S, Sumpter B, Engram J, Moanna A, Paiardini M, Mandl JN, Lawson B, Garg S, McClure HM, Xu YX, Ibegbu C, Easley K, Katz N, Pandrea I, Apetrei C, Sodora DL, Staprans SI, Feinberg MB, Silvestri G.

Blood. 2006 Jul 1;108(1):209-17. Epub 2006 Mar 7.

21.

Perturbations of cell cycle control in T cells contribute to the different outcomes of simian immunodeficiency virus infection in rhesus macaques and sooty mangabeys.

Paiardini M, Cervasi B, Sumpter B, McClure HM, Sodora DL, Magnani M, Staprans SI, Piedimonte G, Silvestri G.

J Virol. 2006 Jan;80(2):634-42.

22.

A combination DNA and attenuated simian immunodeficiency virus vaccine strategy provides enhanced protection from simian/human immunodeficiency virus-induced disease.

Amara RR, Patel K, Niedziela G, Nigam P, Sharma S, Staprans SI, Montefiori DC, Chenareddi L, Herndon JG, Robinson HL, McClure HM, Novembre FJ.

J Virol. 2005 Dec;79(24):15356-67.

23.

SIVsm quasispecies adaptation to a new simian host.

Demma LJ, Logsdon JM Jr, Vanderford TH, Feinberg MB, Staprans SI.

PLoS Pathog. 2005 Sep;1(1):e3. Epub 2005 Sep 30.

24.

Timely triggering of homeostatic mechanisms involved in the regulation of T-cell levels in SIVsm-infected sooty mangabeys.

Muthukumar A, Zhou D, Paiardini M, Barry AP, Cole KS, McClure HM, Staprans SI, Silvestri G, Sodora DL.

Blood. 2005 Dec 1;106(12):3839-45. Epub 2005 Aug 16.

25.

Preclinical assessment of HIV vaccines and microbicides by repeated low-dose virus challenges.

Regoes RR, Longini IM, Feinberg MB, Staprans SI.

PLoS Med. 2005 Aug;2(8):e249. Epub 2005 Jul 19.

26.

Divergent host responses during primary simian immunodeficiency virus SIVsm infection of natural sooty mangabey and nonnatural rhesus macaque hosts.

Silvestri G, Fedanov A, Germon S, Kozyr N, Kaiser WJ, Garber DA, McClure H, Feinberg MB, Staprans SI.

J Virol. 2005 Apr;79(7):4043-54.

27.
28.

Enhanced SIV replication and accelerated progression to AIDS in macaques primed to mount a CD4 T cell response to the SIV envelope protein.

Staprans SI, Barry AP, Silvestri G, Safrit JT, Kozyr N, Sumpter B, Nguyen H, McClure H, Montefiori D, Cohen JI, Feinberg MB.

Proc Natl Acad Sci U S A. 2004 Aug 31;101(35):13026-31. Epub 2004 Aug 23.

29.

The roles of nonhuman primates in the preclinical evaluation of candidate AIDS vaccines.

Staprans SI, Feinberg MB.

Expert Rev Vaccines. 2004 Aug;3(4 Suppl):S5-32. Review.

PMID:
15285703
30.

Human immunodeficiency virus type 2 DNA vaccine provides partial protection from acute baboon infection.

Locher CP, Witt SA, Ashlock BM, Polacino P, Hu SL, Shiboski S, Schmidt AM, Agy MB, Anderson DM, Staprans SI, zur Megede J, Levy JA.

Vaccine. 2004 Jun 2;22(17-18):2261-72.

PMID:
15149785
31.

Roles of target cells and virus-specific cellular immunity in primary simian immunodeficiency virus infection.

Regoes RR, Antia R, Garber DA, Silvestri G, Feinberg MB, Staprans SI.

J Virol. 2004 May;78(9):4866-75.

32.

Blockade of T cell costimulation reveals interrelated actions of CD4+ and CD8+ T cells in control of SIV replication.

Garber DA, Silvestri G, Barry AP, Fedanov A, Kozyr N, McClure H, Montefiori DC, Larsen CP, Altman JD, Staprans SI, Feinberg MB.

J Clin Invest. 2004 Mar;113(6):836-45.

33.

Gp120-alum boosting of a Gag-Pol-Env DNA/MVA AIDS vaccine: poorer control of a pathogenic viral challenge.

Buge SL, Ma HL, Amara RR, Wyatt LS, Earl PL, Villinger F, Montefiori DC, Staprans SI, Xu Y, Carter E, O'Neil SP, Herndon JG, Hill E, Moss B, Robinson HL, McNicholl JM.

AIDS Res Hum Retroviruses. 2003 Oct;19(10):891-900.

PMID:
14585221
34.

Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia.

Silvestri G, Sodora DL, Koup RA, Paiardini M, O'Neil SP, McClure HM, Staprans SI, Feinberg MB.

Immunity. 2003 Mar;18(3):441-52.

35.
36.

Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines.

Amara RR, Villinger F, Staprans SI, Altman JD, Montefiori DC, Kozyr NL, Xu Y, Wyatt LS, Earl PL, Herndon JG, McClure HM, Moss B, Robinson HL.

J Virol. 2002 Aug;76(15):7625-31.

37.

Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine.

Amara RR, Smith JM, Staprans SI, Montefiori DC, Villinger F, Altman JD, O'Neil SP, Kozyr NL, Xu Y, Wyatt LS, Earl PL, Herndon JG, McNicholl JM, McClure HM, Moss B, Robinson HL.

J Virol. 2002 Jun;76(12):6138-46.

38.

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

Amara RR, Villinger F, Altman JD, Lydy SL, O'Neil SP, Staprans SI, Montefiori DC, Xu Y, Herndon JG, Wyatt LS, Candido MA, Kozyr NL, Earl PL, Smith JM, Ma HL, Grimm BD, Hulsey ML, McClure HM, McNicholl JM, Moss B, Robinson HL.

Vaccine. 2002 May 6;20(15):1949-55. Review.

PMID:
11983252
39.

Contribution of peaks of virus load to simian immunodeficiency virus pathogenesis.

Regoes RR, Staprans SI, Feinberg MB, Bonhoeffer S.

J Virol. 2002 Mar;76(5):2573-8.

40.

Emergence of cytotoxic T lymphocyte escape mutations in nonpathogenic simian immunodeficiency virus infection.

Kaur A, Alexander L, Staprans SI, Denekamp L, Hale CL, McClure HM, Feinberg MB, Desrosiers RC, Johnson RP.

Eur J Immunol. 2001 Nov;31(11):3207-17.

41.

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

Amara RR, Villinger F, Altman JD, Lydy SL, O'Neil SP, Staprans SI, Montefiori DC, Xu Y, Herndon JG, Wyatt LS, Candido MA, Kozyr NL, Earl PL, Smith JM, Ma HL, Grimm BD, Hulsey ML, Miller J, McClure HM, McNicholl JM, Moss B, Robinson HL.

Science. 2001 Apr 6;292(5514):69-74.

42.
43.

Simian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection.

Staprans SI, Dailey PJ, Rosenthal A, Horton C, Grant RM, Lerche N, Feinberg MB.

J Virol. 1999 Jun;73(6):4829-39.

44.

Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection.

Harrer T, Harrer E, Kalams SA, Elbeik T, Staprans SI, Feinberg MB, Cao Y, Ho DD, Yilma T, Caliendo AM, Johnson RP, Buchbinder SP, Walker BD.

AIDS Res Hum Retroviruses. 1996 May 1;12(7):585-92.

PMID:
8743084
45.

Activation of virus replication after vaccination of HIV-1-infected individuals.

Staprans SI, Hamilton BL, Follansbee SE, Elbeik T, Barbosa P, Grant RM, Feinberg MB.

J Exp Med. 1995 Dec 1;182(6):1727-37.

47.
49.

Cell-related sequences in the DNA genome of human cytomegalovirus strain AD169.

Shaw SB, Rasmussen RD, McDonough SH, Staprans SI, Vacquier JP, Spector DH.

J Virol. 1985 Sep;55(3):843-8.

Supplemental Content

Loading ...
Support Center